Literature DB >> 19164896

Prion-dependent lethality of sup45 mutants in Saccharomyces cerevisiae.

Denis Kiktev1, Sergey Inge Vechtomov, Galina Zhouravleva.   

Abstract

In yeast Saccharomyces cerevisiae translation termination factors eRF1 (Sup45) and eRF3 (Sup35) are encoded by the essential genes SUP45 and SUP35 respectively. Heritable aggregation of Sup35 results in formation of the yeast prion [PSI(+)]. It is known that combination of [PSI(+)] with some mutant alleles of the SUP35 or SUP45 genes in one and the same haploid yeast cell causes synthetic lethality. In this study, we perform detailed analysis of synthetic lethality between various sup45 nonsense and missense mutations on one hand, and different variants of [PSI(+)] on the other hand. Synthetic lethality with sup45 mutations was detected for [PSI(+)] variants of different stringencies. Moreover, we demonstrate for the first time that in some combinations, synthetic lethality is dominant and occurs at the postzygotic stage after only a few cell divisions. The tRNA suppressor SUQ5 counteracts the prion-dependent lethality of the nonsense alleles but not of the missense alleles of SUP45, indicating that the lethal effect is due to the depletion of Sup45. Synthetic lethality is also suppressed in the presence of the C-proximal fragment of Sup35 (Sup35C) that lacks the prion domain and cannot be included into the prion aggregates. Remarkably, the production of Sup35C in a sup45 mutant strain is also accompanied by an increase in the Sup45 levels, suggesting that translationally active Sup35 up-regulates Sup45 or protects it from degradation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19164896      PMCID: PMC2634454          DOI: 10.4161/pri.1.2.4533

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  49 in total

1.  Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion.

Authors:  Y O Chernoff; G P Newnam; J Kumar; K Allen; A D Zink
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation.

Authors:  Céline Chauvin; Samia Salhi; Catherine Le Goff; Wildriss Viranaicken; Dialo Diop; Olivier Jean-Jean
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism.

Authors:  S S Eaglestone; B S Cox; M F Tuite
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

4.  Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+].

Authors:  Y O Chernoff; S L Lindquist; B Ono; S G Inge-Vechtomov; S W Liebman
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

5.  C-terminal interaction of translational release factors eRF1 and eRF3 of fission yeast: G-domain uncoupled binding and the role of conserved amino acids.

Authors:  K Ebihara; Y Nakamura
Journal:  RNA       Date:  1999-06       Impact factor: 4.942

6.  Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation.

Authors:  S V Paushkin; V V Kushnirov; V N Smirnov; M D Ter-Avanesyan
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

7.  The yeast non-Mendelian factor [ETA+] is a variant of [PSI+], a prion-like form of release factor eRF3.

Authors:  P Zhou; I L Derkatch; S M Uptain; M M Patino; S Lindquist; S W Liebman
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

Review 8.  Eukaryotic release factors (eRFs) history.

Authors:  Sergei Inge-Vechtomov; Galina Zhouravleva; Michel Philippe
Journal:  Biol Cell       Date:  2003 May-Jun       Impact factor: 4.458

9.  Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure.

Authors:  R D Gietz; R H Schiestl; A R Willems; R A Woods
Journal:  Yeast       Date:  1995-04-15       Impact factor: 3.239

10.  The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae.

Authors:  I Stansfield; K M Jones; V V Kushnirov; A R Dagkesamanskaya; A I Poznyakovski; S V Paushkin; C R Nierras; B S Cox; M D Ter-Avanesyan; M F Tuite
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

View more
  6 in total

1.  The role of translation termination factor eRF1 in the regulation of pseudohyphal growth in Saccharomyces cerevisiae cells.

Authors:  G A Zhouravleva; A V Petrova
Journal:  Dokl Biochem Biophys       Date:  2010-08-17       Impact factor: 0.788

Review 2.  Prions in yeast.

Authors:  Susan W Liebman; Yury O Chernoff
Journal:  Genetics       Date:  2012-08       Impact factor: 4.562

3.  Identification of genes influencing synthetic lethality of genetic and epigenetic alterations in translation termination factors in yeast.

Authors:  D A Kiktev; Y O Chernoff; A V Archipenko; G A Zhouravleva
Journal:  Dokl Biochem Biophys       Date:  2011-07-03       Impact factor: 0.788

4.  The paradox of viable sup45 STOP mutations: a necessary equilibrium between translational readthrough, activity and stability of the protein.

Authors:  Denis Kiktev; Svetlana Moskalenko; Olga Murina; Agnès Baudin-Baillieu; Jean-Pierre Rousset; Galina Zhouravleva
Journal:  Mol Genet Genomics       Date:  2009-04-16       Impact factor: 3.291

5.  Amyloid-mediated sequestration of essential proteins contributes to mutant huntingtin toxicity in yeast.

Authors:  Natalia V Kochneva-Pervukhova; Alexander I Alexandrov; Michael D Ter-Avanesyan
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

6.  The Pub1 and Upf1 Proteins Act in Concert to Protect Yeast from Toxicity of the [PSI⁺] Prion.

Authors:  Valery N Urakov; Olga V Mitkevich; Alexander A Dergalev; Michael D Ter-Avanesyan
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.